Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Polivy (polatuzumab vedotin) for the Treatment of Diffuse Large B-cell Lymphoma

Drug Name

Polivy™ (polatuzumab vedotin-piiq)

Developer

Genentech

Therapy Class

Antibody-drug conjugate

Product Description

CD79b-directed antibody-drug conjugate

Current Indication

Diffuse large B-cell lymphoma

Market Sector

Oncology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top